
Director, Regulatory CMC Strategy
Posted 1 day ago

Posted 1 day ago
This is a fully remote position, open to applicants in United States.
β’ Create and implement integrated Regulatory CMC strategies for small molecule programs throughout preclinical development to late-stage clinical development and regulatory submissions.
β’ Offer strategic and technical support across drug substance, drug product, analytical development, manufacturing, and control operations.
β’ Act as the Regulatory CMC subject matter expert within cross-functional program teams.
β’ Align CMC development strategies with clinical, regulatory, quality, and business goals.
β’ Provide strategic regulatory advice on development strategies, regulatory risk evaluation, lifecycle management, and health authority expectations.
β’ Lead the preparation, review, and approval of CMC content for global regulatory submissions and responses, including INDs, CTAs, marketing applications, supplements/variations, briefing documents, and health authority information requests.
β’ Track and interpret changing global regulatory requirements, guidance, and precedents.
β’ Collaborate with external development and manufacturing partners, including oversight of CDMOs, performance management, technology transfer, scale-up, validation, and manufacturing readiness.
β’ Ensure compliance with FDA, EMA, ICH, and cGMP standards while facilitating inspection readiness and supply continuity.
β’ Develop and manage project plans, timelines, budgets, forecasts, and risk mitigation strategies.
β’ Cultivate relationships with internal stakeholders and external partners to advance programs and meet organizational objectives.
β’ A Master's degree in Chemistry, Pharmaceutical Sciences, or a related scientific field is required; a PharmD or PhD is preferred.
β’ Over 8 years of experience in the pharmaceutical industry, with a minimum of 5 years in Regulatory CMC roles supporting small molecule development programs.
β’ Recent and direct experience in leading Regulatory CMC activities for late-stage development programs, including NDA-enabling activities and marketing application submissions, is mandatory.
β’ Demonstrated experience in authoring, reviewing, and managing CMC regulatory filings, including INDs, IMPDs, NDAs, and interactions with global health authorities.
β’ In-depth knowledge of small molecule drug substance and drug product development, analytical development, manufacturing processes, control strategies, and pharmaceutical development principles.
β’ Extensive experience managing CDMOs and external development and manufacturing organizations.
β’ Comprehensive understanding of cGMP requirements, ICH guidelines, FDA regulations, and global Regulatory CMC expectations.
β’ Proven experience supporting programs from early development through IND submission and lifecycle management.
β’ Experience in supporting technology transfer, process development, scale-up, validation, and clinical supply manufacturing activities.
β’ Exceptional leadership, project management, communication, and cross-functional collaboration skills.
β’ Preferred experience in orexin, CNS, or other specialized therapeutic areas.
β’ Company bonus, partially based on both company and individual performance.
β’ Company-sponsored 401(k) plan.
β’ Pension plan.
β’ Vacation benefits.
β’ Medical, dental, vision, and prescription drug coverage.
β’ Flexible benefits, including healthcare and/or dependent day care flexible spending accounts.
β’ Life insurance and death benefits.
β’ Various time off and leave of absence benefits.
β’ Well-being benefits, which include an employee assistance program, fitness benefits, and employee clubs and activities.
β’ Employee resource groups (ERGs) providing support networks.
Invisible Technologies
Expressable
Spark Power β‘
IQVIA
Get handpicked remote jobs straight to your inbox weekly.